相关实验视频

Updated: Jun 29, 2026

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

双子分子组合局部化 (GOAL):准确和有效的融合基因定型用于慢性髓性白血病智能诊断

Yuanyuan Huang¹, Zixin Zhang², Tiantian Yang¹

¹The Center for Clinical Molecular Medical Detection, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, P. R. China.

|April 14, 2025

概括

一个新的双输入,双输出在位成像系统 (GOAL) 准确地检测癌细胞中的RNA异常. 这项技术提高了特异性,减少了假阳性,有助于诊断慢性髓性白血病 (CML) 等疾病.

科学领域:

分子生物学分子生物学
生物技术是生物技术.
癌症研究癌症研究

背景情况:

异常的RNA小片段与各种疾病有关.
目前基于DNA组装的RNA现场分析方法面临着由于组装不当导致的假阳性信号的挑战.
开发通用和简单的方法来避免错误组装对于准确的RNA分析至关重要.

研究的目的:

提出一种新的双输入,双输出现场分析范式,以提高目标特异性和消除错误阳性.
介绍基于这个范式的双子分子组合同定位 (GOAL) 现场成像系统.
为了能够准确地检测和量化RNA小片段异常,特别是慢性髓性白血病 (CML).

主要方法:

开发一个双输入策略,用于共同认可,以提高目标特异性.
实施使用光信号同定位的双输出策略,以消除错误的错误组装.
将GOAL系统与智能细胞图像分类器 (iCis) 集成,用于自动计数和分类.

主要成果:

该GOAL系统准确地区分与CML相关的融合基因亚型.
它准确地报告了临床样本中最小残留癌细胞的比例.
在0.01%度下,GOAL实现了对CML瘤细胞的高度敏感和精确的基因型识别.

结论:

在iCis的协助下,GOAL系统提供了一套创新的多功能工具包,用于分析具有RNA异常的癌细胞.
这种方法提供了准确,快速,用户友好和专业独立的分子分析.
它为疾病诊断和管理提供了有效的临床决策支持.

关键词:

慢性骨髓性白血病慢性骨髓性白血病在现场成像中,双输入到双输出的双输入.光共定位的共定位融合基因型定制 (Fusion Genotyping) 是一种研究方法.智能图像分析智能图像分析

更多相关视频

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...